BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued ...
1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight ...
The CDC study provides the largest window to date into how the bird virus first detected in March in dairy cows may be ...
Wells Fargo analyst Derek Archila maintained a Buy rating on AnaptysBio (ANAB – Research Report) yesterday and set a price target of ...
Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...
One study showed it can wipe out anywhere from 11 to 73 percent of the antibodies that protect against strains of various ...
BioArctic's report for the third quarter 2024 will be published on November 14 at 08.00 a.m. CET. BioArctic's report for the third quarter 2024 will be published onNovember 14at08.00 a.m. CET. This ...
More than 36 hours have passed since a troop of female rhesus macaque monkeys escaped from their enclosure at Alpha Genesis ...
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies third quarter 2024 financial results conference call.
A gene drive to treat herpes, improving clinical trials for immunocompromised people — and Breast Sexual Health Clinic opens.
A modeling study estimates the MenACWY vaccine prevented 500 cases of invasive meningococcal disease in US adolescents from ...